HomeVenture Capital

Venture Capital

Venture Capital

Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development

Life Sciences Times - 0
Venture Capital

Enpro Announces Agreement to Sell GGB to Timken for $305 Million

Life Sciences Times - 0
Venture Capital

Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting

Life Sciences Times - 0
Venture Capital

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Life Sciences Times - 0
Venture Capital

Lendmark Financial Commits to Raising $10M in 10 Years for Childhood Cancer Research

Life Sciences Times - 0
Venture Capital

Biocytogen Lists on the Main Board of HKEX, Aiming to Become the Headstream of New Drugs

Life Sciences Times - 0
Venture Capital

Cadence Completes Acquisition of OpenEye Scientific

Life Sciences Times - 0
Venture Capital

EarlySalary Raises Series D Funding of $110 Million led by TPG’s The Rise Fund & Norwest Venture Partners

Life Sciences Times - 0
Venture Capital

Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S.

Life Sciences Times - 0
Venture Capital

Regenacy Pharmaceuticals Announces Completion of Enrollment for Phase 2 Study in Diabetic Peripheral Neuropathy & $9.3 Million Series B Financing

Life Sciences Times - 0
Venture Capital

Netcapital Funding Portal Powers $1.4 Million Capital Raise by Avadain

Life Sciences Times - 0
Venture Capital

SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Life Sciences Times - 0
1...676869...115Page 68 of 115

Most Read